Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007–2009

Abstract

INH or INH+SM resistance in pulmonary TB patients in Georgia is common. The low rates of treatment success suggest the need for an improved treatment regimen for patients with resistance to these first-line drugs; this need is particularly pronounced among the subset of patients with a history of previous treatment.